The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Phenylephrine is widely used in a variety of over-the-counter flu and cold medicines, including popular products such as Benadryl ... the ingredient Companies such as Procter & Gamble and GSK were ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

"Strong growth in specialty medicines helped to offset lower vaccine sales and reflected successful new product ... GSK opened 1.9-percent lower in London following the results update. Over-the ...

Sri Lanka’s leading e-commerce platform, Daraz, has officially launched its annual 11.11 shopping festival, known as the ...

Pipeline progress was strongly evident in the quarter with a series of filings and data readouts supporting future product ... GSK, reflecting the combination of successful R&D and, BD investment ...

This means the FTSE 100 stock is down 16% in the past six months and 21% over five years. Should I invest in GSK shares at £14? Or is this an investment to avoid? Let’s dig in. Despite its ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners ... virus (RSV), mRESVIA. GSK claims Moderna is marketing the products in violation of its ...

Haleon--which houses Sensodyne toothpaste and Aquafresh mouthwash as well as over-the-counter medicines Panadol and Advil--posted organic revenue growth of 6.1%. The company had guided revenue growth ...

GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. Explore more details here.

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...